Multicystic dedifferentiated retroperitoneal liposarcoma: tumour cyst fluid analysis and implications for management

Liposarcomas are soft tissue sarcomas of adipocyte origin. We describe a case of a dedifferentiated retroperitoneal liposarcoma with an unusual presentation on recurrence as a large, multicystic tumour. The patient was a 72-year-old woman who had undergone multiple treatments including two prior resections. For her most recent locoregional disease recurrence, the patient was offered surgical debulking for symptom palliation. At this operation, performed after two cycles of chemotherapy, the tumour cyst fluid was analysed and found to have a predominance of immune cells with no identifiable malignant cells. This case and the results of our tumour cyst fluid analysis raise several interesting considerations for the management of this unique situation in a rare disease.

[1]  P. Hwu,et al.  Analysis of the Intratumoral Adaptive Immune Response in Well Differentiated and Dedifferentiated Retroperitoneal Liposarcoma , 2015, Sarcoma.

[2]  S. Singhal,et al.  Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer. , 2014, The Journal of clinical investigation.

[3]  V. Bronte,et al.  Myeloid‐derived suppressor cell heterogeneity in human cancers , 2014, Annals of the New York Academy of Sciences.

[4]  Atique U. Ahmed,et al.  Depletion of myeloid-derived suppressor cells during interleukin-12 immunogene therapy does not confer a survival advantage in experimental malignant glioma , 2014, Cancer Gene Therapy.

[5]  L. Dodd Update on Liposarcoma: A review for cytopathologists , 2012, Diagnostic cytopathology.

[6]  Hyun-Jeong Ko,et al.  The restoration of myeloid‐derived suppressor cells as functional antigen‐presenting cells by NKT cell help and all‐trans‐retinoic acid treatment , 2012, International journal of cancer.

[7]  A. Lazar,et al.  Lymphocyte composition and distribution in inflammatory, well-differentiated retroperitoneal liposarcoma: clues to a potential adaptive immune response and therapeutic implications. , 2012, The American journal of surgical pathology.

[8]  V. Bronte,et al.  Myeloid-derived suppressor cell heterogeneity and subset definition. , 2010, Current opinion in immunology.

[9]  J. Coindre,et al.  Well-differentiated and dedifferentiated liposarcomas , 2010, Virchows Archiv.

[10]  Marc E. Rothenberg,et al.  Regulation of Carcinogenesis by IL-5 and CCL11: A Potential Role for Eosinophils in Tumor Immune Surveillance1 , 2007, The Journal of Immunology.

[11]  Christopher Chiu,et al.  Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis , 2006, Proceedings of the National Academy of Sciences.

[12]  J. Thomas,et al.  Surgical management of primary and recurrent retroperitoneal liposarcoma , 2005, The British journal of surgery.

[13]  K. Hoag,et al.  Physiological concentrations of retinoic acid favor myeloid dendritic cell development over granulocyte development in cultures of bone marrow cells from mice. , 2004, The Journal of nutrition.

[14]  Bin Yu,et al.  All-trans-retinoic acid eliminates immature myeloid cells from tumor-bearing mice and improves the effect of vaccination. , 2003, Cancer research.

[15]  A. Horiguchi,et al.  [Perinephric liposarcoma mimicking cystic renal tumor]. , 2002, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

[16]  R. Pollock,et al.  Soft Tissue Sarcomas , 2001, CA: a cancer journal for clinicians.

[17]  D. Shibata,et al.  Is there a role for incomplete resection in the management of retroperitoneal liposarcomas? , 2001, Journal of the American College of Surgeons.

[18]  R. Benjamin,et al.  Phase II clinical investigation of gemcitabine in advanced soft tissue sarcomas and window evaluation of dose rate on gemcitabine triphosphate accumulation. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  D. Gabrilovich,et al.  Mechanism of Immune Dysfunction in Cancer Mediated by Immature Gr-1+ Myeloid Cells1 , 2001, The Journal of Immunology.

[20]  J. Posen,et al.  Lymphocyte-rich pleural liposarcoma mimicking pericardial cyst. , 2000, The Journal of thoracic and cardiovascular surgery.

[21]  P. Argani,et al.  Lymphocyte-rich well-differentiated liposarcoma: report of nine cases. , 1997, The American journal of surgical pathology.

[22]  L. Guillou,et al.  Well-differentiated inflammatory liposarcoma: an uncommon and easily overlooked variant of a common sarcoma. , 1997, The American journal of surgical pathology.

[23]  C. Karakousis,et al.  Soft tissue sarcomas in adults , 1994, CA: a cancer journal for clinicians.

[24]  B Sundell,et al.  Soft-tissue sarcomas. , 1979, British medical journal.

[25]  L. Schwartz,et al.  New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). , 2009, European journal of cancer.

[26]  H. Huland,et al.  Tumor-associated eosinophilia in interleukin-2-treated patients: evidence of toxic eosinophil degranulation on bladder cancer cells , 2005, Journal of Cancer Research and Clinical Oncology.